MRKR Insider Trading

22.39% of Marker Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Marker Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
3/11/2024	Vanguard Group Inc.	225,057	$1.24M	0.0%	+1.8%	2.532%
2/15/2024	Vanguard Group Inc.	225,057	$1.24M	0.0%	+1.8%	2.532%
2/13/2024	Northern Trust Corp	38,711	$0.21M	0.0%	+255.8%	0.435%
1/25/2024	International Assets Investment Management LLC	11,000	$60K	0.0%	+1,000.0%	0.124%
1/24/2024	International Assets Investment Management LLC	11,000	$60K	0.0%	+1,000.0%	0.124%
12/18/2023	Vanguard Group Inc.	221,082	$1M	0.0%	+33.5%	2.487%
10/12/2023	Matrix Asset Advisors Inc. NY	15,000	$68K	0.0%	-62.5%	0.170%
8/11/2023	Renaissance Technologies LLC	31,950	$99K	0.0%	+65.1%	0.363%
7/27/2023	Virtu Financial LLC	20,472	$63K	0.0%	N/A	0.233%
7/18/2023	Matrix Asset Advisors Inc. NY	40,000	$0.12M	0.0%	+60.0%	0.455%
5/17/2023	Long Focus Capital Management LLC	146,100	$0.10M	0.0%	-90.0%	1.660%
5/16/2023	Geode Capital Management LLC	57,751	$41K	0.0%	-90.0%	0.656%
5/12/2023	Long Focus Capital Management LLC	68,400	$49K	0.0%	-95.3%	0.777%
5/9/2023	Aisling Capital Management LP	314,286	$0.22M	0.1%	-90.0%	3.571%
5/9/2023	AR Asset Management Inc.	40,700	$29K	0.0%	N/A	0.463%
2/15/2023	Millennium Management LLC	169,320	$45K	0.0%	N/A	2.025%
2/13/2023	Renaissance Technologies LLC	163,200	$43K	0.0%	+7.7%	1.952%
1/19/2023	Matrix Asset Advisors Inc. NY	250,000	$68K	0.0%	-37.5%	0.299%
11/15/2022	Vanguard Group Inc.	1,766,291	$0.65M	0.0%	-23.4%	2.113%
11/15/2022	Long Focus Capital Management LLC	1,461,000	$0.54M	0.1%	-40.0%	1.748%
11/14/2022	Renaissance Technologies LLC	151,500	$56K	0.0%	-43.4%	0.181%
10/25/2022	Raymond James & Associates	94,000	$35K	0.0%	N/A	0.112%
10/24/2022	Matrix Asset Advisors Inc. NY	400,000	$0.15M	0.0%	+60.0%	0.478%
8/15/2022	Millennium Management LLC	92,142	$30K	0.0%	-60.4%	0.110%
8/13/2022	Renaissance Technologies LLC	267,700	$88K	0.0%	-54.2%	0.320%
7/15/2022	Matrix Asset Advisors Inc. NY	250,000	$83K	0.0%	+66.7%	0.299%
5/13/2022	Renaissance Technologies LLC	584,272	$0.26M	0.0%	-45.3%	0.703%
5/13/2022	Vanguard Group Inc.	2,307,294	$1.02M	0.0%	-14.2%	2.777%
5/10/2022	AR Asset Management Inc.	279,000	$0.12M	0.0%	+290.2%	0.336%
4/19/2022	Wedbush Securities Inc.	90,068	$40K	0.0%	+44.0%	0.108%
2/15/2022	Kennedy Capital Management Inc.	590,118	$0.56M	0.0%	-3.5%	0.710%
2/14/2022	Long Focus Capital Management LLC	1,233,257	$1.17M	0.2%	N/A	1.484%
2/10/2022	Matrix Asset Advisors Inc. NY	150,000	$0.14M	0.0%	N/A	0.181%
2/10/2022	Acadian Asset Management LLC	39,507	$37K	0.0%	N/A	0.048%
2/7/2022	Victory Capital Management Inc.	621,670	$0.59M	0.0%	-31.4%	0.748%
2/7/2022	AR Asset Management Inc.	71,500	$68K	0.0%	-74.4%	0.086%
2/3/2022	ACT Capital Management LLC	354,400	$0.34M	0.2%	-19.3%	0.427%
11/16/2021	ACT Capital L.L.C.	439,400	$0.74M	0.4%	+4.6%	0.529%
11/16/2021	Two Sigma Advisers LP	878,300	$1.48M	0.0%	-35.2%	1.057%
11/16/2021	Two Sigma Investments LP	887,009	$1.50M	0.0%	-11.3%	1.068%
11/15/2021	Marshall Wace LLP	170,712	$0.29M	0.0%	-47.9%	0.205%
11/12/2021	Renaissance Technologies LLC	985,100	$1.67M	0.0%	+146.3%	1.186%
11/8/2021	Mandatum Life Insurance Co Ltd	99,000	$0.17M	0.0%	N/A	0.119%
11/5/2021	Advisor Group Holdings Inc.	44,713	$76K	0.0%	-13.4%	0.054%
11/2/2021	Victory Capital Management Inc.	906,770	$1.53M	0.0%	-1.8%	1.091%
10/19/2021	Vigilare Wealth Management	102,500	$0.17M	0.1%	-7.2%	0.123%
9/3/2021	Parametric Portfolio Associates LLC	75,068	$0.21M	0.0%	-17.2%	0.090%
8/25/2021	Marshall Wace LLP	327,826	$0.92M	0.0%	N/A	0.395%
8/17/2021	Millennium Management LLC	1,364,632	$3.81M	0.0%	+515.8%	1.643%
8/17/2021	Bridgeway Capital Management LLC	162,216	$0.45M	0.0%	-15.1%	0.195%
8/16/2021	AQR Capital Management LLC	41,524	$0.12M	0.0%	N/A	0.050%
8/16/2021	LMR Partners LLP	14,387	$40K	0.0%	N/A	0.017%
8/16/2021	Cubist Systematic Strategies LLC	47,344	$0.13M	0.0%	-34.2%	0.057%
8/16/2021	Kennedy Capital Management Inc.	601,342	$1.68M	0.0%	-66.8%	0.724%
8/16/2021	Charles Schwab Investment Management Inc.	26,562	$75K	0.0%	-64.0%	0.032%
8/16/2021	State Street Corp	192,751	$0.54M	0.0%	-66.5%	0.232%
8/16/2021	Goldman Sachs Group Inc.	136,241	$0.38M	0.0%	+442.8%	0.164%
8/16/2021	Marshall Wace LLP	327,826	$0.92M	0.0%	N/A	0.395%
8/13/2021	Renaissance Technologies LLC	399,900	$1.12M	0.0%	N/A	0.481%
8/13/2021	Northern Trust Corp	114,693	$0.32M	0.0%	-65.8%	0.138%
8/13/2021	Geode Capital Management LLC	546,849	$1.53M	0.0%	+12.5%	0.690%
8/13/2021	Vanguard Group Inc.	2,691,710	$7.51M	0.0%	+5.6%	3.394%
8/12/2021	XTX Topco Ltd	24,167	$67K	0.0%	N/A	0.030%
8/12/2021	Dimensional Fund Advisors LP	68,352	$0.19M	0.0%	+22.9%	0.086%
8/12/2021	Ergoteles LLC	137,400	$0.38M	0.0%	N/A	0.173%
8/11/2021	Commonwealth Equity Services LLC	17,829	$49K	0.0%	N/A	0.022%
8/11/2021	Bank of New York Mellon Corp	15,757	$44K	0.0%	-79.8%	0.020%
8/11/2021	Susquehanna Fundamental Investments LLC	43,153	$0.12M	0.0%	N/A	0.054%
8/10/2021	National Asset Management Inc.	82,600	$0.23M	0.0%	N/A	0.104%
8/4/2021	AR Asset Management Inc.	280,000	$0.78M	0.2%	N/A	0.353%
8/4/2021	Creative Planning	150,361	$0.42M	0.0%	-6.8%	0.190%
8/3/2021	Victory Capital Management Inc.	923,683	$2.58M	0.0%	-6.4%	1.165%
8/2/2021	Advisor Group Holdings Inc.	51,613	$0.14M	0.0%	+162.5%	0.065%
7/31/2021	Vigilare Wealth Management	110,500	$0.31M	0.2%	-13.4%	0.139%
5/18/2021	Millennium Management LLC	221,602	$0.50M	0.0%	+988.4%	0.279%
5/18/2021	Cubist Systematic Strategies LLC	71,981	$0.16M	0.0%	N/A	0.091%
5/18/2021	Jane Street Group LLC	24,768	$55K	0.0%	N/A	0.031%
5/18/2021	California State Teachers Retirement System	47,011	$0.11M	0.0%	+11.4%	0.059%
5/17/2021	Caas Capital Management LP	48,141	$0.11M	0.0%	N/A	0.061%
5/14/2021	Kennedy Capital Management Inc.	1,809,520	$4.05M	0.1%	N/A	2.282%
5/14/2021	NEA Management Company LLC	10,714,285	$24M	0.5%	+114.3%	13.511%
5/13/2021	Bank of New York Mellon Corp	77,941	$0.17M	0.0%	-17.9%	0.098%
5/13/2021	Bank of Montreal Can	15,139	$33K	0.0%	+213.0%	0.019%
5/12/2021	Northern Trust Corp	335,058	$0.75M	0.0%	-4.0%	0.423%
5/12/2021	Geode Capital Management LLC	486,026	$1.09M	0.0%	-7.6%	0.613%
5/12/2021	JPMorgan Chase & Co.	37,482	$83K	0.0%	-38.1%	0.047%
5/12/2021	Brinker Capital Investments LLC	28,446	$64K	0.0%	N/A	0.036%
5/12/2021	UBS Group AG	17,204	$39K	0.0%	+105.1%	0.022%
5/10/2021	Jaffetilchin Investment Partners LLC	30,000	$67K	0.0%	N/A	0.038%
5/10/2021	HighTower Advisors LLC	17,178	$38K	0.0%	N/A	0.022%
5/7/2021	BlackRock Inc.	2,076,042	$4.65M	0.0%	+0.5%	2.618%
5/4/2021	Victory Capital Management Inc.	986,466	$2.21M	0.0%	N/A	1.244%
4/29/2021	Vigilare Wealth Management	127,600	$0.29M	0.2%	-10.0%	0.161%
4/14/2021	WealthTrust Axiom LLC	22,700	$50K	0.0%	N/A	0.029%
4/12/2021	FNY Investment Advisers LLC	17,000	$38K	0.0%	N/A	0.021%
2/24/2021	Virtu Financial LLC	76,223	$0.11M	0.0%	+80.5%	0.159%
2/19/2021	JPMorgan Chase & Co.	60,543	$87K	0.0%	+403.1%	0.126%
2/16/2021	Squarepoint Ops LLC	30,258	$44K	0.0%	N/A	0.063%
2/11/2021	Northern Trust Corp	348,982	$0.51M	0.0%	+2.1%	0.727%
2/10/2021	Rhumbline Advisers	25,208	$37K	0.0%	+15.3%	0.052%

Data available starting January 2016

Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications in the United States. Its MultiTAA-specific T cell technology is based on the manufacture of non-engineered tumor-specific T cells that recognize multiple tumor-associated antigens and kill tumor cells. The company's MultiTAA-specific T cell therapies include autologous T cells for the treatment of lymphoma and selected solid tumors; allogeneic T cells for the treatment of acute myeloid leukemia (AML) and acute lymphoblastic leukemia; and off-the-shelf products in various indications. It is also developing MT-401, which is in Phase 2 clinical trial for the treatment of post-transplant AML; MT-401-OTS for the treatment of AML; and MT-601 for the treatment of pancreatic cancer and lymphoma. Marker Therapeutics was founded in 1999 and is headquartered in Houston, Texas.

Today's Range

Now: $4.10

$4.09

$4.40

50 Day Range

MA: $4.26

$3.63

$4.91

52 Week Range

Now: $4.10

$0.76

$9.68

Volume

13,050 shs

Average Volume

21,056 shs

Market Capitalization

$36.49 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.5

Who are the company insiders with the largest holdings of Marker Therapeutics?: Marker Therapeutics' top insider shareholders include:
Norman David Eansor (Director)
Learn More about top insider investors at Marker Therapeutics.